Approval · Notice of Compliance 13001 · 2012
LOPERAMIDE: Notice of Compliance 13001
Issued February 1, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13001
- Date
- February 1, 2012
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Oral Antidiarrheal Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOPERAMIDE | 02377764 | Approved |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB